ATRECA
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Aug 2019)
What this means for you
This application is over — abandoned 12 Aug 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86838031
- Mark type
- Stylized text
- Filed
- 03 Dec 2015
- Published for opposition
- 17 May 2016
- Abandoned
- 12 Aug 2019
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 001 — Chemicals: Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of biological tissue cultures for research and scientific diagnosis use; combinations of antibody reagents for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research
- Class 005 — Pharmaceuticals: Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal diseases; biologics, namely, biological tissue cultures for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal diseases; combinations of biologics, namely, biological tissue cultures, antibodies, and vaccines, for medical diagnosis
Owner
- Atreca, Inc., Redwood City, CA, US
- Atreca, Inc., Redwood City, CA, US
Prosecution history
- 12 Aug 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2018 — SOU EXTENSION 5 GRANTED
- 26 Nov 2018 — SOU EXTENSION 5 FILED
- 04 Dec 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Nov 2018 — SOU TEAS EXTENSION RECEIVED
- 14 Jul 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jul 2018 — SOU EXTENSION 4 GRANTED
- 12 Jul 2018 — SOU EXTENSION 4 FILED
- 12 Jul 2018 — SOU TEAS EXTENSION RECEIVED
- 16 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2018 — SOU EXTENSION 3 GRANTED
- 12 Jan 2018 — SOU EXTENSION 3 FILED
- 12 Jan 2018 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED